Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-26-003539

CVP, Chief Financial Officer sold 13,000 shares at an average $84.92 ($1,103,896)

  • CVP, Chief Financial Officer acquired 13,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ullem Scott B. · CVP, Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2026-03-11 Exercise or conversion : show line 1 in the form 10b5-1 +13,000 $59.26 $770,337 52,699 D
2026-03-11 Sale : show line 2 in the form 10b5-1 −5,099 $84.46 $430,668 47,600 D
2026-03-11 Sale : show line 3 in the form 10b5-1 −7,901 $85.21 $673,228 39,699 D
Open-market sales · 13,000 sh · avg $84.92 · $1,103,896

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-11 Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Acquire) −13,000 26,000 D
Loading xslF345X05/doc4.xml…